The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
NCT05564936
This study is recruiting at 9 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG. ME\&MG contains digital active tests for the assessment of ptosis, breathing, dysarthria, upper- and lower-limb (arms and legs) weakness, treatment follow-up, and validated e-questionnaires related to daily activities, pain, fatigue, sleep, and depression disorders.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Myasthenia Gravis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Ad scientiam
- Last updated on ClinicalTrials.gov
- April 11, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- University of Colorado Denver · Aurora, CO
Florida · 1
- University of Florida Health · Jacksonville, FL
Indiana · 1
- Indiana University Health · Indianapolis, IN
Kentucky · 1
- University of Kentucky · Lexington, KY
New York · 1
- Neurological Associates of Long Island, P.C. · Lake Success, NY
North Carolina · 1
- Duke University · Durham, NC
Oregon · 1
- OHSU · Portland, OR
Pennsylvania · 1
- Thomas Jefferson University · Philadelphia, PA
Tennessee · 1
- Vanderbilt Health · Nashville, TN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.